OncoMark -Products


OncoMasTR is a novel prognostic assay for early stage breast cancer currently being developed by OncoMark. This multi biomarker panel will determine the risk of recurrence for early breast cancer patients as either high or low risk. This assay will aid the clinicians to determine the best treatment options for their patients. » read more

'Pipeline Assays' image

Pipeline Assays

OncoMark has a range of tissue-based biomarker assays in development. These assays are suited to: Pharmacodynamic studies and Patient Stratification studies. Assessing disease progression and patient survival » read more